InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Marks that use Swiss flag ruled invalid


On September 5 2012 the Court of Gravenhage in the Netherlands issued its decision in a procedure between amongst others Recticel, a Swiss manufacturer of beds and mattresses, and Swiss Sense, a Dutch company in the same sector.

Recticel opposed the registration of several trade marks and trade mark applications by Sense (shown above). It argued that Sense misled the public as to geographical origin of its products by using trade marks and a trade name which contain the verbal...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @AdamMossoff: one of millions #patent deals driving #innovation economy - http://t.co/guGWfimaHn - contrary to false arg that patents st…

Jul 1 2015 07:53 ·  reply ·  retweet ·  favourite
ManagingIP profile

.@EuropeanCommiss EU - Latin America survey on IPRs, internationalisation & SMEs http://t.co/u6XVOBZqPz

Jul 1 2015 04:31 ·  reply ·  retweet ·  favourite
ManagingIP profile

How automotive industry is putting the brakes on NPEs with PTAB petitions & defensive patent aggregators http://t.co/an6Z5ePu8l ($/trial)

Jul 1 2015 03:58 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


INTA Daily News 2015

Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego


June 2015

The fine line between abuse and fair use at the PTAB

Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system



Most read articles

Supplements